The trajectory of Viagra, originally marketed by copyright, presents a complex case study for stakeholders considering the pharmaceutical arena . Although its early success and creation of vast in sales, the intellectual property end has opened the door for generic medications, significantly diminishing earnings opportunities. This shift raises dou